CHAPTER 1. Industry Overview of Drug Discovery Market
1.1. Definition and Scope
1.1.1. Definition of Drug Discovery
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Drug Discovery Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Drug Discovery Market By Drug Type
1.2.3. Drug Discovery Market By Technology
1.2.4. Drug Discovery Market By End-User
1.2.5. Drug Discovery Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Drug Discovery Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Drug Discovery Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2022
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Drug Discovery Market By Drug Type
4.1. Introduction
4.2. Drug Discovery Market Revenue By Drug Type
4.2.1. Drug Discovery Market Revenue (USD Million) and Forecast, By Drug Type, 2020-2032
4.2.2. Biologic Drugs
4.2.2.1. Biologic Drugs Market Revenue (USD Million) and Growth Rate (%), 2020-2032
4.2.3. Small Molecule Drugs
4.2.3.1. Small Molecule Drugs Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 5. Drug Discovery Market By Technology
5.1. Introduction
5.2. Drug Discovery Market Revenue By Technology
5.2.1. Drug Discovery Market Revenue (USD Million) and Forecast, By Technology, 2020-2032
5.2.2. High Throughput Screening
5.2.2.1. High Throughput Screening Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Spectroscopy
5.2.3.1. Spectroscopy Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4. Combinatorial Chemistry
5.2.4.1. Combinatorial Chemistry Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.5. Biochips
5.2.5.1. Biochips Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.6. Pharmacogenomics and Pharmacogenetics
5.2.6.1. Pharmacogenomics and Pharmacogenetics Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.7. Bioinformatics
5.2.7.1. Bioinformatics Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.8. Metabolomics
5.2.8.1. Metabolomics Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.9. Nanotechnology
5.2.9.1. Nanotechnology Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.10. Other Technologies
5.2.10.1. Other Technologies Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Drug Discovery Market By End-User
6.1. Introduction
6.2. Drug Discovery Market Revenue By End-User
6.2.1. Drug Discovery Market Revenue (USD Million) and Forecast, By End-User, 2020-2032
6.2.2. Pharmaceutical Companies
6.2.2.1. Pharmaceutical Companies Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Contract Research Organizations (CROs)
6.2.3.1. Contract Research Organizations (CROs) Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.4. Other End-Users
6.2.4.1. Other End-Users Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. North America Drug Discovery Market By Country
7.1. North America Drug Discovery Market Overview
7.2. U.S.
7.2.1. U.S. Drug Discovery Market Revenue (USD Million) and Forecast By Drug Type, 2020-2032
7.2.2. U.S. Drug Discovery Market Revenue (USD Million) and Forecast By Technology, 2020-2032
7.2.3. U.S. Drug Discovery Market Revenue (USD Million) and Forecast By End-User, 2020-2032
7.3. Canada
7.3.1. Canada Drug Discovery Market Revenue (USD Million) and Forecast By Drug Type, 2020-2032
7.3.2. Canada Drug Discovery Market Revenue (USD Million) and Forecast By Technology, 2020-2032
7.3.3. Canada Drug Discovery Market Revenue (USD Million) and Forecast By End-User, 2020-2032
7.4. North America PEST Analysis
CHAPTER 8. Europe Drug Discovery Market By Country
8.1. Europe Drug Discovery Market Overview
8.2. U.K.
8.2.1. U.K. Drug Discovery Market Revenue (USD Million) and Forecast By Drug Type, 2020-2032
8.2.2. U.K. Drug Discovery Market Revenue (USD Million) and Forecast By Technology, 2020-2032
8.2.3. U.K. Drug Discovery Market Revenue (USD Million) and Forecast By End-User, 2020-2032
8.3. Germany
8.3.1. Germany Drug Discovery Market Revenue (USD Million) and Forecast By Drug Type, 2020-2032
8.3.2. Germany Drug Discovery Market Revenue (USD Million) and Forecast By Technology, 2020-2032
8.3.3. Germany Drug Discovery Market Revenue (USD Million) and Forecast By End-User, 2020-2032
8.4. France
8.4.1. France Drug Discovery Market Revenue (USD Million) and Forecast By Drug Type, 2020-2032
8.4.2. France Drug Discovery Market Revenue (USD Million) and Forecast By Technology, 2020-2032
8.4.3. France Drug Discovery Market Revenue (USD Million) and Forecast By End-User, 2020-2032
8.5. Spain
8.5.1. Spain Drug Discovery Market Revenue (USD Million) and Forecast By Drug Type, 2020-2032
8.5.2. Spain Drug Discovery Market Revenue (USD Million) and Forecast By Technology, 2020-2032
8.5.3. Spain Drug Discovery Market Revenue (USD Million) and Forecast By End-User, 2020-2032
8.6. Rest of Europe
8.6.1. Rest of Europe Drug Discovery Market Revenue (USD Million) and Forecast By Drug Type, 2020-2032
8.6.2. Rest of Europe Drug Discovery Market Revenue (USD Million) and Forecast By Technology, 2020-2032
8.6.3. Rest of Europe Drug Discovery Market Revenue (USD Million) and Forecast By End-User, 2020-2032
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Drug Discovery Market By Country
9.1. Asia Pacific Drug Discovery Market Overview
9.2. China
9.2.1. China Drug Discovery Market Revenue (USD Million) and Forecast By Drug Type, 2020-2032
9.2.2. China Drug Discovery Market Revenue (USD Million) and Forecast By Technology, 2020-2032
9.2.3. China Drug Discovery Market Revenue (USD Million) and Forecast By End-User, 2020-2032
9.3. Japan
9.3.1. Japan Drug Discovery Market Revenue (USD Million) and Forecast By Drug Type, 2020-2032
9.3.2. Japan Drug Discovery Market Revenue (USD Million) and Forecast By Technology, 2020-2032
9.3.3. Japan Drug Discovery Market Revenue (USD Million) and Forecast By End-User, 2020-2032
9.4. India
9.4.1. India Drug Discovery Market Revenue (USD Million) and Forecast By Drug Type, 2020-2032
9.4.2. India Drug Discovery Market Revenue (USD Million) and Forecast By Technology, 2020-2032
9.4.3. India Drug Discovery Market Revenue (USD Million) and Forecast By End-User, 2020-2032
9.5. Australia
9.5.1. Australia Drug Discovery Market Revenue (USD Million) and Forecast By Drug Type, 2020-2032
9.5.2. Australia Drug Discovery Market Revenue (USD Million) and Forecast By Technology, 2020-2032
9.5.3. Australia Drug Discovery Market Revenue (USD Million) and Forecast By End-User, 2020-2032
9.6. South Korea
9.6.1. South Korea Drug Discovery Market Revenue (USD Million) and Forecast By Drug Type, 2020-2032
9.6.2. South Korea Drug Discovery Market Revenue (USD Million) and Forecast By Technology, 2020-2032
9.6.3. South Korea Drug Discovery Market Revenue (USD Million) and Forecast By End-User, 2020-2032
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Drug Discovery Market Revenue (USD Million) and Forecast By Drug Type, 2020-2032
9.7.2. Rest of Asia-Pacific Drug Discovery Market Revenue (USD Million) and Forecast By Technology, 2020-2032
9.7.3. Rest of Asia-Pacific Drug Discovery Market Revenue (USD Million) and Forecast By End-User, 2020-2032
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Drug Discovery Market By Country
10.1. Latin America Drug Discovery Market Overview
10.2. Brazil
10.2.1. Brazil Drug Discovery Market Revenue (USD Million) and Forecast By Drug Type, 2020-2032
10.2.2. Brazil Drug Discovery Market Revenue (USD Million) and Forecast By Technology, 2020-2032
10.2.3. Brazil Drug Discovery Market Revenue (USD Million) and Forecast By End-User, 2020-2032
10.3. Mexico
10.3.1. Mexico Drug Discovery Market Revenue (USD Million) and Forecast By Drug Type, 2020-2032
10.3.2. Mexico Drug Discovery Market Revenue (USD Million) and Forecast By Technology, 2020-2032
10.3.3. Mexico Drug Discovery Market Revenue (USD Million) and Forecast By End-User, 2020-2032
10.4. Rest of Latin America
10.4.1. Rest of Latin America Drug Discovery Market Revenue (USD Million) and Forecast By Drug Type, 2020-2032
10.4.2. Rest of Latin America Drug Discovery Market Revenue (USD Million) and Forecast By Technology, 2020-2032
10.4.3. Rest of Latin America Drug Discovery Market Revenue (USD Million) and Forecast By End-User, 2020-2032
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Drug Discovery Market By Country
11.1. Middle East & Africa Drug Discovery Market Overview
11.2. GCC
11.2.1. GCC Drug Discovery Market Revenue (USD Million) and Forecast By Drug Type, 2020-2032
11.2.2. GCC Drug Discovery Market Revenue (USD Million) and Forecast By Technology, 2020-2032
11.2.3. GCC Drug Discovery Market Revenue (USD Million) and Forecast By End-User, 2020-2032
11.3. South Africa
11.3.1. South Africa Drug Discovery Market Revenue (USD Million) and Forecast By Drug Type, 2020-2032
11.3.2. South Africa Drug Discovery Market Revenue (USD Million) and Forecast By Technology, 2020-2032
11.3.3. South Africa Drug Discovery Market Revenue (USD Million) and Forecast By End-User, 2020-2032
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Drug Discovery Market Revenue (USD Million) and Forecast By Drug Type, 2020-2032
11.4.2. Rest of Middle East & Africa Drug Discovery Market Revenue (USD Million) and Forecast By Technology, 2020-2032
11.4.3. Rest of Middle East & Africa Drug Discovery Market Revenue (USD Million) and Forecast By End-User, 2020-2032
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Drug Discovery Market
12.1. Drug Discovery Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Drug Discovery Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Abbott Laboratories Inc.
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Million), 2022
13.1.3.2. Abbott Laboratories Inc. 2022 Drug Discovery Business Regional Distribution
13.1.4. Product /Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. Agilent Technologies Inc.
13.3. AstraZeneca PLC
13.4. Bayer AG
13.5. Eli Lilly and Company
13.6. F. Hoffmann-La Roche Ltd
13.7. GlaxoSmithKline PLC
13.8. Merck & Co. Inc.
13.9. Pfizer Inc.
13.10. Shimadzu Corp
The size of drug discovery market was USD 81.5 billion in 2022.
The drug discovery market CAGR during the analysis period of 2023 to 2032 is 8.5%.
The key players operating in the global drug discovery market are Abbott Laboratories Inc., Agilent Technologies Inc., AstraZeneca PLC, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, Merck & Co. Inc., Pfizer Inc., and Shimadzu Corp.
North America region held the dominating position in drug discovery industry during the analysis period of 2023 to 2032.
Asia-Pacific region exhibited fastest growing CAGR for market of drug discovery during the analysis period of 2023 to 2032.
The current trends and dynamics in the drug discovery industry include increasing prevalence of chronic and rare diseases, technological advancements like AI and automation expediting drug development processes, and rising investment and funding from both private and public sectors
The small molecule drugs type held the maximum share of the drug discovery industry.?
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date